Roshan Agarwal
Overview
Explore the profile of Roshan Agarwal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
2512
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Desai O, Kshirsagar R, Singh V, Nair V, Sane V, Jain S, et al.
Cureus
. 2024 May;
16(4):e57729.
PMID: 38711708
This article presents a clinical case of a central giant cell granuloma (CGCG) resembling a periapical lesion of endodontic origin. A 39-year-old, otherwise healthy male patient was referred to the...
2.
3.
Wu O, McCartney E, Heggie R, Germeni E, Paul J, Soulis E, et al.
Health Technol Assess
. 2021 Jul;
25(47):1-126.
PMID: 34318743
Background: Venous access devices are used for patients receiving long-term chemotherapy. These include centrally inserted tunnelled catheters or Hickman-type devices (Hickman), peripherally inserted central catheters (PICCs) and centrally inserted totally...
4.
Moss J, Wu O, Bodenham A, Agarwal R, Menne T, Jones B, et al.
Lancet
. 2021 Jul;
398(10298):403-415.
PMID: 34297997
Background: Hickman-type tunnelled catheters (Hickman), peripherally inserted central catheters (PICCs), and totally implanted ports (PORTs) are used to deliver systemic anticancer treatment (SACT) via a central vein. We aimed to...
5.
Harvey R, Elias K, Lim A, Bercow A, Short D, Horowitz N, et al.
Curr Probl Cancer
. 2020 Aug;
45(1):100622.
PMID: 32800689
Background: Methotrexate is the most common first-line chemotherapy for low-risk gestational trophoblastic neoplasia (GTN). Uterine artery pulsatility index (UAPI) is an ultrasound marker for tumor vascularity that has been associated...
6.
Robertson L, Yeoh S, Broderick C, Stansby G, Agarwal R
Cochrane Database Syst Rev
. 2018 Nov;
11:CD010837.
PMID: 30407621
Background: Venous thromboembolism (VTE) is a collective term for two conditions: deep vein thrombosis (DVT) and pulmonary embolism (PE). A proportion of people with VTE have no underlying or immediately...
7.
Robertson L, Yeoh S, Stansby G, Agarwal R
Cochrane Database Syst Rev
. 2017 Aug;
8:CD010837.
PMID: 28832905
Background: Venous thromboembolism (VTE) is a collective term for two conditions: deep vein thrombosis (DVT) and pulmonary embolism (PE). A proportion of people with VTE have no underlying or immediately...
8.
Mateo-Carrasco H, Kostrzynski O, Ndefo O, Stapley S, Davies E, Agarwal R
Int J Clin Pharm
. 2017 Apr;
39(4):657-661.
PMID: 28444546
Safety: non-occurrence of grade ≥3 toxicities (according to the common terminology criteria for adverse events v4). Results Three patients were treated (mean age: 62-years), pre-SACT levels were 0.629 ± 0.121 ...
9.
Propper D, Jones K, Anthoney D, Mansoor W, Ford D, Eatock M, et al.
BMC Cancer
. 2016 Oct;
16(1):779.
PMID: 27724887
Background: TP300, a recently developed synthetic camptothecin analogue, is a highly selective topoisomerase I inhibitor. A phase I study showed good safety and tolerability. As camptothecins have proven active in...
10.
Li Y, Tang M, Agarwal R, Patel D, Eckersley R, Barrois G, et al.
Ultraschall Med
. 2016 Aug;
39(2):206-212.
PMID: 27529457
Purpose: The FIGO score cannot accurately stratify low-risk gestational trophoblastic neoplasia (GTN) patients who develop chemoresistance to single agent methotrexate chemotherapy. Tumour vascularisation is a key risk factor and its...